929
Participants
Start Date
January 31, 2008
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
liraglutide
0.6 mg/day, s.c. (under the skin) injection
placebo
Glimepiride placebo, capsules
liraglutide
1.2 mg/day, s.c. (under the skin) injection
liraglutide
1.8 mg/day, s.c. (under the skin) injection
glimepiride
Capsules, 4.0 mg/day
metformin
Tablets, 1.5-2.0 g/day
placebo
Liraglutide placebo, s.c. (under the skin) injection
Novo Nordisk Investigational Site, Suwon
Novo Nordisk Investigational Site, Beijing
Novo Nordisk Investigational Site, Beijing
Novo Nordisk Investigational Site, Shenyang
Novo Nordisk Investigational Site, New Delhi
Novo Nordisk Investigational Site, New Dehli
Novo Nordisk Investigational Site, Harbin
Novo Nordisk Investigational Site, Harbin
Novo Nordisk Investigational Site, Shanghai
Novo Nordisk Investigational Site, Nanjing
Novo Nordisk Investigational Site, Wuxi
Novo Nordisk Investigational Site, Suzhou
Novo Nordisk Investigational Site, Tianjin
Novo Nordisk Investigational Site, Jaipur
Novo Nordisk Investigational Site, Hangzhou
Novo Nordisk Investigational Site, Fuzhou
Novo Nordisk Investigational Site, Chongqing
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Wuhan
Novo Nordisk Investigational Site, Wuhan
Novo Nordisk Investigational Site, Visakhapatnam
Novo Nordisk Investigational Site, Kochi
Novo Nordisk Investigational Site, Trivandrum
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Kolkata
Novo Nordisk Investigational Site, Xi'an
Novo Nordisk Investigational Site, Bhubaneswar
Novo Nordisk Investigational Site, Patna
Novo Nordisk Investigational Site, Hyderabad
Novo Nordisk Investigational Site, Hyderbad
Novo Nordisk Investigational Site, Ahmedabad
Novo Nordisk Investigational Site, Bangalore
Novo Nordisk Investigational Site, Pune
Novo Nordisk Investigational Site, Chennai
Novo Nordisk Investigational Site, Madurai
Novo Nordisk Investigational Site, Ghaziabad
Novo Nordisk Investigational Site, Kochi
Novo Nordisk Investigational Site, Mumbai
Novo Nordisk Investigational Site, Secunderabad
Novo Nordisk Investigational Site, Goyang
Novo Nordisk Investigational Site, Incheon
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Seoul
Novo Nordisk Investigational Site, Sungnam
Lead Sponsor
Novo Nordisk A/S
INDUSTRY